Back to search

Article

Retroviral Replicating Vector Toca 511 (<i>vocimagene amiretrorepvec</i>) for Prodrug Activator Gene Therapy of Lung Cancer

2022-07-01

Abstract excerpt

Therapeutic efficacy of retroviral replicating vector (RRV)-mediated prodrug activator gene therapy has been demonstrated in a variety of tumor models, but clinical investigation of this approach has so far been restricted to glioma and gastrointestinal malignancies. In the present study, we evaluated replication kinetics, transduction efficiency, and therapeutic efficacy of RRV in experimental models of lung canc...

Identifiers and source

Literature Corpus work
3f97db38-01c6-5fc6-a2e2-0cb231e65d2b
DOI
10.20944/preprints202207.0015.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Retroviral Replicating Vector Toca 511 (<i>vocimagene amiretrorepvec</i>) for Prodrug Activator Gene Therapy of Lung CancerDOI 10.20944/preprints202207.0015.v1
Select a neighboring publication to make it the new centre.